REPLY

Affiliations

¹ Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
² Statistics and Data Center, Samsung Medical Center, Seoul, Korea.

Comment

Myung Ji Goh et al. Hepatology. 2021 Apr.

. 2021 Apr;73(4):1622-1623.

doi: 10.1002/hep.31567. Epub 2021 Mar 16.

¹ Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
² Statistics and Data Center, Samsung Medical Center, Seoul, Korea.

No abstract available

Comment on

Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Goh MJ, Sinn DH, Kim S, Woo SY, Cho H, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Goh MJ, et al. Hepatology. 2020 Jun;71(6):2023-2032. doi: 10.1002/hep.30973. Epub 2020 Feb 14. Hepatology. 2020. PMID: 31556128
Letter to the Editor: Statin Reduces the Risk of Hepatocellular Carcinoma Development in Patients With CHB.
Zhang BH, Cai YS, Song JL, Lyu T, Yang J, Jiang L, Yang JY. Zhang BH, et al. Hepatology. 2021 Apr;73(4):1621-1622. doi: 10.1002/hep.31563. Epub 2021 Mar 16. Hepatology. 2021. PMID: 32965687 No abstract available.

1. Goh MJ, Sinn DH, Kim S, Woo SY, Cho H, Kang W, et al. Statin use and the risk of hepatocellular carcinoma in patients with chronic hepatitis B. Hepatology 2020;71:2023-2032.
1. Snapinn SM, Jiang Q, Iglewicz B. Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator. Am Stat 2005;59:301-307.
1. Nunan D, Heneghan C, Spencer EA. Catalogue of bias: allocation bias. BMJ Evid Based Med 2018;23:20-21.
1. Li X, Sheng L, Liu L, Hu Y, Chen Y, Lou L. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis. BMC Gastroenterol 2020;20:98.